Jaguar Health, Inc. (NASDAQ: JAGX) reported Q3 EPS of ($0.12), $0.04 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $3.15 million versus the consensus estimate of $3.55 million.

For earnings history and earnings-related data on Jaguar Health, Inc. (JAGX) click here.